Pediatric Cataract Surgery Outcomes Registry
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 12-003467
About this study
This study is being done to learn about cataract surgery in children. The study involves the collection of information about children who have had cataract surgery. This information will include when the child developed cataract, how the cataract has been treated, problems that may have occurred related to surgery, and whether anyone else in the family has had a cataract. Doctors throughout the United States and possibly other parts of the world are taking part in the study. We hope that gathering the information from many children we can improve the care of children with cataracts.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Children who have had cataract surgery(ies) within the last 45 days for one or both eyes:
- Less than 13 years of age at time of surgery (if had bilateral surgeries at the time of enrollment,.
- Less than 13 years of age at time of surgery in at least one eye.
- Subjects with traumatic cataracts.
- Subjects with ocular comorbidities such as a persistent hyperplastic primary vitreous (PHPV, a.k.a. persistent fetal vasculature), retinopathy of prematurity, or Peter’s anomaly.
Exclusion Criteria:
- Parents do not expect to remain in area for the next year.
- Follow-up at the study center is not possible.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Erick Bothun, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available